Tubulin seeds alpha-synuclein fibril formation
- PMID: 11698390
- DOI: 10.1074/jbc.M102981200
Tubulin seeds alpha-synuclein fibril formation
Abstract
Increasing evidence suggests that alpha-synuclein is a common pathogenic molecule in several neurodegenerative diseases, particularly in Parkinson's disease. To understand alpha-synuclein pathology, we investigated molecules that interact with alpha-synuclein in human and rat brains and identified tubulin as an alpha-synuclein binding/associated protein. Tubulin co-localized with alpha-synuclein in Lewy bodies and other alpha-synuclein-positive pathological structures. Tubulin initiated and promoted alpha-synuclein fibril formation under physiological conditions in vitro. These findings suggest that an interaction between tubulin and alpha-synuclein might accelerate alpha-synuclein aggregation in diseased brains, leading to the formation of Lewy bodies.
Similar articles
-
p25alpha Stimulates alpha-synuclein aggregation and is co-localized with aggregated alpha-synuclein in alpha-synucleinopathies.J Biol Chem. 2005 Feb 18;280(7):5703-15. doi: 10.1074/jbc.M410409200. Epub 2004 Dec 7. J Biol Chem. 2005. PMID: 15590652
-
alpha-Synuclein is phosphorylated in synucleinopathy lesions.Nat Cell Biol. 2002 Feb;4(2):160-4. doi: 10.1038/ncb748. Nat Cell Biol. 2002. PMID: 11813001
-
Biophysical properties of the synucleins and their propensities to fibrillate: inhibition of alpha-synuclein assembly by beta- and gamma-synucleins.J Biol Chem. 2002 Apr 5;277(14):11970-8. doi: 10.1074/jbc.M109541200. Epub 2002 Jan 25. J Biol Chem. 2002. PMID: 11812782
-
Alpha-synuclein aggregation.Protein Pept Lett. 2004 Jun;11(3):271-9. doi: 10.2174/0929866043407084. Protein Pept Lett. 2004. PMID: 15182228 Review.
-
The role of alpha-synuclein in neurodegenerative diseases.Pharmacol Ther. 2005 Mar;105(3):311-31. doi: 10.1016/j.pharmthera.2004.10.010. Epub 2004 Dec 8. Pharmacol Ther. 2005. PMID: 15737408 Review.
Cited by
-
Linking acetylated α-Tubulin redistribution to α-Synuclein pathology in brain of Parkinson's disease patients.NPJ Parkinsons Dis. 2024 Jan 2;10(1):2. doi: 10.1038/s41531-023-00607-9. NPJ Parkinsons Dis. 2024. PMID: 38167511 Free PMC article.
-
Acetylated α-Tubulin and α-Synuclein: Physiological Interplay and Contribution to α-Synuclein Oligomerization.Int J Mol Sci. 2023 Jul 31;24(15):12287. doi: 10.3390/ijms241512287. Int J Mol Sci. 2023. PMID: 37569662 Free PMC article.
-
Novel loss of function mutation in TUBA1A gene compromises tubulin stability and proteostasis causing spastic paraplegia and ataxia.Front Cell Neurosci. 2023 Jun 23;17:1162363. doi: 10.3389/fncel.2023.1162363. eCollection 2023. Front Cell Neurosci. 2023. PMID: 37435044 Free PMC article.
-
Parkinson's disease: From genetics to molecular dysfunction and targeted therapeutic approaches.Genes Dis. 2022 Feb 5;10(3):786-798. doi: 10.1016/j.gendis.2021.12.015. eCollection 2023 May. Genes Dis. 2022. PMID: 37396535 Free PMC article. Review.
-
Rotenone-Induced Model of Parkinson's Disease: Beyond Mitochondrial Complex I Inhibition.Mol Neurobiol. 2023 Apr;60(4):1929-1948. doi: 10.1007/s12035-022-03193-8. Epub 2023 Jan 3. Mol Neurobiol. 2023. PMID: 36593435 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous
